Journal of Hepatology
Volume 56, Supplement 1 , Pages S1-S12, 2012

Management of bacterial infections in cirrhosis

  • Javier Fernández

      Affiliations

    • Liver Unit, IMDiM, Hospital Clínic, Universidad de Barcelona, IDIBAPS and CIBERehd
    • Corresponding Author InformationAddress: Liver Unit, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain. Tel.: +34 93 2275400 2204/4030; fax: +34 93 4515522
  • ,
  • Thierry Gustot

      Affiliations

    • Dept. of Gastroenterology and Hepato-Pancreatology, Erasme Hospital, Brussels, Belgium
    • Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Brussels, Belgium
    • INSERM, U773, Centre de Recherche Biomédicale Bichat-Beaujon CRB3, Paris 75018, France

Summary 

Bacterial infections are very frequent in advanced cirrhosis and become the first cause of death of these patients. Despite numerous experimental data and significant advances in the understanding of the pathogenesis of sepsis in cirrhosis, the outcome remains poor. Classical diagnostic parameters such as C-reactive protein and SIRS criteria have less diagnostic capacity in the cirrhotic population, often delaying the diagnosis and the management of bacterial infection. Prompt and appropriate empirical antibiotic treatment of infection and early resuscitation of patients with severe sepsis or septic shock are essential in determining patient's outcome. A strategy of careful restriction of prophylactic antibiotics to the high-risk populations could reduce the spread of multidrug resistant bacteria. This review is focused on the currently recommended diagnostic, therapeutic and prophylactic strategies for bacterial infections in the cirrhotic population.

Keywords:  Diagnosis , Antibiotic treatment , Early-goal therapy , CRP , Procalcitonin , SIRS criteria , Third-generation cephalosporins , Quinolones , ESBL-producing enterobacteria , Antibiotic resistance , Albumin

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8278(12)60002-6

doi:10.1016/S0168-8278(12)60002-6

Journal of Hepatology
Volume 56, Supplement 1 , Pages S1-S12, 2012